![](jpg/oncology%20-%20gettyimages-1130151355_0.jpg)
Photo: KARRASTOCK/Getty Images
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with cancer care support company OncoPower to offer prescription drugs at a decreased cost via a platform dubbed Medication Savings Suite.
The suite will be integrated within OncoPower's Pill Reminder Tool, which will alert patients of cheaper generic medication options available through MCCPDC when patients log a new medication into the tool.
OncoPower offers oncology patients counseling, cancer community support groups, educational videos, access to experts and information on clinical trials.
"We are excited to work with OncoPower to bring lower prescription drug prices to consumers," Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company, said in a statement. "Cost Plus Drugs and OncoPower share a common goal of providing consumers the lowest possible price for their prescription medication. With Cost Plus Drugs, consumers can be confident they are getting a fair price and the convenience of medication mailed directly to their homes."
THE LARGER TREND
Earlier this month, MCCPDC announced a partnership with pharmacy benefit manager RxPreferred Benefits, marking the company's third PBM collaboration. The company previously partnered with EmsanaRx and Rightway.
"We are working on adding partnerships with PBMs that share our mission of cost-plus pricing, transparency and no rebates. RxPreferred will help us extend our mission," Mark Cuban told MobiHealthNews in an email in December.
In October, Texas-based MCCPDC announced its first health plan partnership with Capital Blue Cross, which allows Capital members and community organizers to access lower-cost drugs via MCCPDC's platform.